Homovanillate Test

Homovanillic acid, often abbreviated HVA, is the main end product of dopamine metabolism. Dopamine is a neurotransmitter, meaning a chemical messenger that brain cells use to communicate. It plays central roles in motivation, reward, movement, attention, and mood regulation.

After dopamine is released and has transmitted its signal, it is broken down by enzymes, primarily monoamine oxidase and catechol O methyltransferase. Enzymes are proteins that speed up chemical reactions in the body. These enzymes convert dopamine stepwise into several intermediate compounds and ultimately into homovanillic acid. This final product circulates in blood and is excreted in urine. Because HVA reflects how much dopamine has been produced and broken down, it is considered a marker of dopamine turnover. Turnover refers to the balance between how much of a substance is made, released, and metabolized.

HVA is produced not only in the brain but also in peripheral tissues such as the liver, lungs, skeletal muscle, and sympathetic nerves. The sympathetic nervous system is the branch of the autonomic nervous system that drives the fight or flight response. This means that plasma or urine HVA is not a pure measure of brain dopamine activity. Still, changes in HVA can provide indirect insight into the overall state of the dopaminergic system, especially when interpreted in the context of symptoms and other clinical findings.

In schizophrenia, a psychiatric disorder characterized by hallucinations, delusions, cognitive impairment, and negative symptoms such as low motivation or reduced emotional expression, dopamine dysregulation is a core feature. Untreated patients often show elevated plasma HVA compared with healthy controls. In some studies, higher HVA levels correlate with greater severity of negative symptoms, particularly in men. This supports the long standing dopamine hypothesis of schizophrenia, which proposes that abnormal dopamine signaling contributes to symptom development.

In psychotic depression, particularly in women with melancholic features, plasma HVA can be markedly elevated. This suggests that certain forms of severe depression involve increased dopamine turnover. However, HVA levels do not diagnose psychiatric conditions on their own. They reflect a biological process that must be interpreted alongside clinical evaluation.

Acute stress and exercise can increase HVA by roughly one third. Stress activates the sympathetic nervous system, increasing dopamine and norepinephrine release. Increased release leads to increased breakdown, and therefore higher HVA. On the other hand, reduced kidney function can raise blood HVA simply because it is not cleared efficiently. For example, congestive heart failure may lead to several fold elevations in HVA due to impaired renal clearance rather than increased dopamine production. This distinction is critical when interpreting results.

Low HVA can reflect reduced dopamine production or turnover. In pure autonomic failure, a condition involving degeneration of autonomic nerves, total HVA production falls substantially. However, plasma levels may appear normal if kidney clearance also decreases, masking the true reduction in dopamine activity. In research settings, lower cerebrospinal fluid HVA has been associated with certain emotional states, such as lower anxiety in some female suicide attempters. Cerebrospinal fluid, or CSF, is the fluid that surrounds the brain and spinal cord and more directly reflects central nervous system chemistry than blood.

Sex differences in HVA are consistent and biologically significant. Women generally have higher HVA levels than men across the lifespan. This difference is not reversed by cross sex hormone treatment in transgender individuals, suggesting it may reflect genetic factors or early developmental effects of sex hormones rather than adult circulating estrogen or testosterone levels. Estrogen appears to modulate dopamine turnover. Menopause or removal of the ovaries has been associated with higher CSF HVA, implying that endogenous estrogen may suppress dopamine metabolism in certain brain regions. Plasma HVA does not fluctuate significantly across the menstrual cycle in healthy women, highlighting that central and peripheral measures can behave differently.

Age also influences HVA levels, with older adults tending to show higher plasma concentrations than younger individuals. This may reflect changes in dopamine metabolism, clearance, or both.

For individuals focused on healthspan and cognitive longevity, HVA offers a window into dopaminergic biology, which is relevant not only to psychiatric illness but also to neurodegenerative disorders and age related cognitive decline. It is not a standalone diagnostic tool. It is best understood as a systems level signal that integrates dopamine production, release, metabolism, stress physiology, renal function, sex biology, and aging. Context is essential.